Koyfin Home > Directory > Health Care > Gilead Sciences Inc > EBITDA

Gilead Sciences Inc EBITDA Chart (GILD)

Gilead Sciences Inc annual/quarterly EBITDA from 2010 to 2020. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Gilead Sciences Inc EBITDA for the quarter ending June 06, 2020 was $1,890m a 159.58% increase of 3,016m year over year
  • Gilead Sciences Inc EBITDA for the last 12 months ending June 06, 2020 was $5,564m a -23.31% decrease of -1,297m year over year
  • Gilead Sciences Inc Annual EBITDA for 2019 was $6,491m a -60.98% decrease of -3,958m from 2018
  • Gilead Sciences Inc Annual EBITDA for 2018 was $10,449m a -47.48% decrease of -4,961m from 2017
  • Gilead Sciences Inc Annual EBITDA for 2017 was $15,410m a -24.74% decrease of -3,813m from 2016
Other Income Statement Metrics:
  • Gilead Sciences Inc Net Income for the quarter ending December 12, 2018 was $3m a -51,166.67% decrease of -1,535m year over year
  • Gilead Sciences Inc Total Revenue for the quarter ending December 12, 2018 was $5,795m a 12.20% increase of 707m year over year
View Chart On Koyfin

Quarterly GILD EBITDA Data

06/2020$1,890m
03/2020$2,751m
12/2019$2,243m
09/2019$-1,126m
06/2019$2,943m
03/2019$2,596m
12/2018$2,322m
09/2018$2,981m
06/2018$2,636m
03/2018$2,510m

Annual GILD EBITDA Data

2019$6,491m
2018$10,449m
2017$15,410m
2016$19,223m
2015$23,291m
2014$16,315m
2013$4,869m
2012$4,577m
2011$4,121m
2010$4,228m